Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Statement

23 May 2019 07:00

RNS Number : 9062Z
Sabre Insurance Group PLC
23 May 2019
 

 

23 May 2019

SABRE INSURANCE GROUP PLC

 

Trading Update

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading private motor insurance underwriters, today provides an update on trading for the period ending 30 April 2019 ahead of its AGM later this morning.

 

· Continued strategy of prioritising underwriting profitability over volume, with the competitive market dynamics observed in FY18 continuing through the first four months of this year

· Anticipated full year Combined Ratio slightly better than mid 70% target

· Gross written premium down £5m YOY (£64.7m V £69.8m) as expected with Sabre maintaining its strategy of countering claims inflation with ongoing price increases to preserve underwriting discipline and target margins

· Continued strong organic capital generation with a solvency coverage ratio of 185% (post payment of 2018 full year dividend) exceeding our preferred range of 140 to 160%

 

Geoff Carter, Chief Executive Officer of Sabre, commented:

 

"We are pleased to report results for the first four months of the year which are very much in line with our expectations. Our continued focus on our stated strategy has delivered strong underwriting margins and capital generation.

As anticipated, premium is down in the early months of the year as we continue to cover claims inflation through price increases against the backdrop of a continued competitive environment. We are very comfortable with our premium position at this point in the cycle and believe our strategy positions us well for growth when the market turns.

The outlook for our full year GWP position continues to be in a range depending on the timing of this market turn, but at this stage feels likely to be slightly down year on year.

We remain confident in delivering on our guidance for the full year, including a COR slightly better than our long term target, strong capital generation and an attractive dividend, as we continue to execute our long established and successful strategy."

 

Investor enquiries

0330 024 4696

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Tulchan Communications

sabre@tulchangroup.com

James Macey White

David Ison

Amber Ahluwalia

 

LEI Code: 2138006RXRQ8P8VKGV98

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDUBBDBGCD
Date   Source Headline
7th Jul 20257:00 amRNSTransaction in Own Shares
4th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20257:00 amRNSTransaction in Own Shares
17th Jun 20254:35 pmRNSDirector/PDMR Shareholding
11th Jun 20251:38 pmRNSDirector/PDMR Shareholding
5th Jun 202511:16 amRNSDirector/PDMR Shareholding
22nd May 202511:38 amRNSResult of AGM
22nd May 20257:00 amRNSTrading Update
13th May 20253:18 pmRNSDirector/PDMR Shareholding
17th Apr 20259:40 amRNSDirector/PDMR Shareholding
11th Apr 20251:26 pmRNSDirector/PDMR Shareholding
10th Apr 20251:09 pmRNSDirector/PDMR Shareholding
8th Apr 20254:31 pmRNSDirector/PDMR Shareholding
8th Apr 20253:54 pmRNSDirector/PDMR Shareholding
8th Apr 20251:53 pmRNSDirector/PDMR Shareholding
4th Apr 20253:20 pmRNSNotice of AGM
27th Mar 20258:37 amRNSDirector/PDMR Shareholding
20th Mar 202511:39 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSFinal Results
11th Mar 20251:21 pmRNSDirector/PDMR Shareholding
24th Feb 202511:23 amRNSNotice of Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:14 pmRNSDirector/PDMR Shareholding
11th Dec 202411:57 amRNSDirector/PDMR Shareholding
5th Dec 20247:00 amRNSCapital Markets Event
21st Nov 202410:28 amRNSAppointment of Joint Corporate Broker
12th Nov 20241:15 pmRNSDirector/PDMR Shareholding
23rd Oct 20244:13 pmRNSHolding(s) in Company
22nd Oct 20242:43 pmRNSDirector/PDMR Shareholding
22nd Oct 20242:40 pmRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update
18th Oct 20243:25 pmRNSHolding(s) in Company
11th Oct 202412:40 pmRNSDirector/PDMR Shareholding
26th Sep 20241:25 pmRNSDirector/PDMR Shareholding
11th Sep 202412:21 pmRNSDirector/PDMR Shareholding
11th Sep 20249:51 amRNSHolding(s) in Company
6th Sep 20242:29 pmRNSHolding(s) in Company
30th Aug 202411:50 amRNSDirector/PDMR Shareholding
22nd Aug 20244:22 pmRNSHolding(s) in Company
14th Aug 20243:33 pmRNSHolding(s) in Company
13th Aug 202412:48 pmRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSHalf-year Report 2024
22nd Jul 20247:00 amRNSNotice of Results
11th Jul 202412:25 pmRNSDirector/PDMR Shareholding
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.